- Home
- LGND vs FULT Comparison
LGND vs FULT Comparison
Compare LGND & FULT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LGND | FULT |
|---|---|---|
| Founded | 1987 | 1882 |
| Country | United States | United States |
| Employees | 68 | 3400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LGND | FULT |
|---|---|---|
| Price | $210.74 | $20.98 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 4 |
| Target Price | ★ $256.29 | $21.75 |
| AVG Volume (30 Days) | 162.9K | ★ 1.7M |
| Earning Date | 05-07-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.55% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.25 | $6.39 |
| Revenue Next Year | $19.41 | $5.52 |
| P/E Ratio | $76.27 | ★ $10.58 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $98.90 | $16.60 |
| 52 Week High | $247.38 | $22.99 |
Technical Indicators
Market Signals| Indicator | LGND | FULT |
|---|---|---|
| Relative Strength Index (RSI) | 42.39 | 46.86 |
| Support Level | $198.23 | $19.05 |
| Resistance Level | $232.12 | $21.01 |
| Average True Range (ATR) | 9.52 | 0.47 |
| MACD | -2.47 | -0.12 |
| Stochastic Oscillator | 30.90 | 31.37 |
Price Performance
Historical ComparisonAbout LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About FULT Fulton Financial Corporation
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.